Rajiv De Silva Takes Helm of Venus Concept

Venus Concept Inc. has appointed Rajiv De Silva as CEO and a member of the Board of Directors. Da Silva replaces Domenic Serafino.

“We are excited to have Rajiv join the Company to lead Venus Concept through its next stage of growth and development,” Board Chairman and Director Scott Barry said. “He is a seasoned executive with significant experience in larger, multinational healthcare companies. Rajiv has a proven track of record of managing companies through multiple stages of growth—both organically and inorganically—and through complex turnarounds that included organizational restructuring and capital structure transformation. With Rajiv at the helm, the board feels the company has a strong leader to execute its strategic objectives of achieving sustainable, profitable, growth in the global medical aesthetics and hair restoration markets and advancing product development, including our next generation robotic technology platform for medical aesthetic applications.”
 
De Silva currently serves as chairman of Covis Pharma, a privately-held, multinational specialty pharmaceutical company, and is a co-founder of Asiri Skincare, a privately-held company focused on topical consumer therapeutic skincare products. From 2013 to 2016, he served as president, CEO and Director of Endo International Plc, a publicly traded multinational specialty pharmaceutical company. Prior to Endo, De Silva served as president of Valeant Pharmaceuticals International Inc. (now Bausch Health) from 2010 to 2013, and as chief operating officer of Valeant’s Specialty Pharmaceuticals business, which included its flagship dermatology and aesthetics unit, from 2009 to 2013. From 2003 to 2008, he held multiple leadership positions within Novartis AG, including president, Novartis Pharma Canada. De Silva started his career in healthcare at McKinsey & Company in 1995, where he rose to partner.

De Silva earned a BSE with honors from Princeton University, an MS from Stanford University, and an MBA with Distinction from the Wharton School at the University of Pennsylvania.
 
“I am delighted to join Venus Concept at a pivotal time for the company,” Da Silva said. “I believe the company’s products and R&D capabilities provide a platform to create meaningful partnerships with aesthetics professionals and make a difference in the lives of consumers. I am excited by the opportunity to build on the company’s past successes and achieve near-term profitability and sustainable, long-term growth.”
 
“On behalf of the board, I would like to express to Dom [Serafino] our deep gratitude for his 12 years of service to our company. From his early days as a co-founder, his vision and leadership fueled the notable growth of Venus Concept to an established, publicly-traded company today,” Barry said. “His legacy will be substantial: he built a company that is an innovative, global leader in the medical aesthetic technology market, with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies. We wish him continued personal growth in his future endeavors.”
 
Venus Concept is a global medical aesthetic technology firm with a product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 18 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems include NeoGraft and the ARTAS and ARTAS iX Robotic Hair Restoration systems. Venus Concept has been backed by healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.